Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer

Giampietro Gasparini, Massimo Gion, Luigi Mariani, Paola Papaldo, Diana Crivellari, Gianfranco Filippelli, Alessandro Morabito, Vittorio Silingardi, Francesco Torino, Antonella Spada, Matelda Zancan, Livia De Sio, Antonio Caputo, Francesco Cognetti, Antonio Lambiase, Dino Amadori

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences